Question: why did ocgn stock drop?
Answer: Shares fell 72% on the news, and kept falling after Histogenics decided to suspend development of the product in December 2018. The Ocugen deal is a way to salvage some limited value. Ocugen sold $25 million of stock in a private placement before the merger.